Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MiMedx Group, Inc - Common Stock (NQ: MDXG )

9.100 +0.020 (+0.22%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MiMedx Group, Inc - Common Stock

< Previous 1 2 3 Next >
MiMedx Group: Q2 Earnings Insights
MiMedx Group (NASDAQ:MDXG) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings MiMedx Group missed estimated... 
Via Benzinga
Earnings Outlook For MiMedx Group
MiMedx Group (NASDAQ:MDXG) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that MiMedx Group... 
Via Benzinga
MiMedx Group's Return on Invested Capital Insights
Benzinga Pro data, MiMedx Group (NASDAQ:MDXG) reported Q1 sales of $58.89 million. Earnings fell to a loss of $10.49 million, resulting in a 573.54% decrease from last quarter. 
Via Benzinga
Recap: MiMedx Group Q1 Earnings
MiMedx Group (NASDAQ:MDXG) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings MiMedx Group missed estimated... 
Via Benzinga
Earnings Outlook For MiMedx Group
MiMedx Group (NASDAQ:MDXG) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that MiMedx Group... 
Via Benzinga
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Progenity (NASDAQ:PROG) shares increased by 17.0% to $1.1 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 40.5... 
Via Benzinga
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion. 
Via Benzinga
Recap: MiMedx Group Q4 Earnings
MiMedx Group (NASDAQ:MDXG) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
86 Biggest Movers From Yesterday
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million.... 
Via Benzinga
Earnings Scheduled For November 2, 2021
Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •... 
Via Benzinga
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
Mid-Afternoon Market Update: Dow Rises Over 100 Points; Itamar Medical Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.38% to 34,739.18 while the NASDAQ fell 0.27% to 15,074.10. The S&P also fell, dropping 0.07% to 4,455.53. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
72 Biggest Movers From Yesterday
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead... 
Via Benzinga
Dow Set to Snap Skid, Eyes Best Day in a Month
The Dow Jones Industrial Index is seeing a dramatic rebound off its five-day slump, last seen up 263 points and on track for its best single-session gain since Aug. 5. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Why Shares of MiMedx Are Collapsing Today
The company released data for two drug programs and missed its goals on both. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Itamar Medical (NASDAQ:ITMR) shares increased by 46.58% to $30.25 during Monday's regular session. Trading volume for Itamar Medical's stock is 2.6 million... 
Via Benzinga
Mid-Day Market Update: Crude Oil Up 1%; MiMedx Group Shares Plummet
Midway through trading Monday, the Dow traded up 0.80% to 34,885.46 while the NASDAQ fell 0.10% to 15,100.02. The S&P also rose, gaining 0.23% to 4,468.75. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
45 Stocks Moving In Monday's Mid-Day Session
Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)... 
Via Benzinga
Mid-Morning Market Update: Markets Mixed; UK Terminates Valneva's COVID-19 Vaccine Contract
Following the market opening Monday, the Dow traded up 0.61% to 34,817.26 while the NASDAQ fell 0.40% to 15,055.69. The S&P also rose, gaining 0.05% to 4,460.84. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures COVID-19 US Equities
Why MiMedx Shares Are Diving Today
MiMedx Group Inc (NASDAQ: MDXG) is trading significantly lower Monday after the company announced top-line results from two late-stage musculoskeletal clinical trials. ... 
Via Benzinga
Mimedx Stock Plunges After Disappointing Data From Musculoskeletal Trials
MiMedx Group Inc (NASDAQ: MDXG) stock dropped after announcing top-line results from two musculoskeletal trials of micronized dehydrated Human Amnion Chorion... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Itamar Medical (NASDAQ:ITMR) shares moved upwards by 44.37% to $29.8 during Monday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... 
Via Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.